Save time and get answers to complex questions with AI chat
Antiox mebendazole price?Somatuline depot patent expiry date?Guselkumab loss of exclusitivy?Dabrafenib and trametinib cost?Xiaflex market launch year?
See the DrugPatentWatch profile for Descovy
Descovy (tenofovir alafenamide fumarate + emtricitabine) is a brand‑name HIV medication that’s still relatively expensive, especially if you’re paying out‑of‑pocket. Here’s a quick snapshot of what you can expect in the U.S.:
Why so pricey? Descovy is a patented combination drug, so there’s no generic yet. The manufacturer (Merck) sets the list price, and pharmacies mark up on top of that. The high cost reflects the drug’s development expenses and the fact that it’s a cornerstone therapy for HIV.
What can lower your cost?
Practical next steps
Bottom line: Without insurance, a 30‑day supply of Descovy can run $3 000–$4 000. With insurance, the copay can be as low as $10–$50 per month. If you’re struggling with the cost, reach out to a pharmacist, your provider, or the Merck patient assistance program to see what discounts or assistance are available.
Other Questions About Descovy :